These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24213858)

  • 1. Modifiers of heart and muscle function: where genetics meets physiology.
    Swaggart KA; McNally EM
    Exp Physiol; 2014 Apr; 99(4):621-6. PubMed ID: 24213858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-latent TGFβ binding protein 4 antibody improves muscle function and reduces muscle fibrosis in muscular dystrophy.
    Demonbreun AR; Fallon KS; Oosterbaan CC; Vaught LA; Reiser NL; Bogdanovic E; Velez MP; Salamone IM; Page PGT; Hadhazy M; Quattrocelli M; Barefield DY; Wood LD; Gonzalez JP; Morris C; McNally EM
    Sci Transl Med; 2021 Sep; 13(610):eabf0376. PubMed ID: 34516828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ.
    Lamar KM; Bogdanovich S; Gardner BB; Gao QQ; Miller T; Earley JU; Hadhazy M; Vo AH; Wren L; Molkentin JD; McNally EM
    PLoS Genet; 2016 May; 12(5):e1006019. PubMed ID: 27148972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic modifiers of muscular dystrophy act on sarcolemmal resealing and recovery from injury.
    Quattrocelli M; Capote J; Ohiri JC; Warner JL; Vo AH; Earley JU; Hadhazy M; Demonbreun AR; Spencer MJ; McNally EM
    PLoS Genet; 2017 Oct; 13(10):e1007070. PubMed ID: 29065150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct genetic regions modify specific muscle groups in muscular dystrophy.
    Swaggart KA; Heydemann A; Palmer AA; McNally EM
    Physiol Genomics; 2011 Jan; 43(1):24-31. PubMed ID: 20959497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene.
    Licandro SA; Crippa L; Pomarico R; Perego R; Fossati G; Leoni F; Steinkühler C
    Skelet Muscle; 2021 Jul; 11(1):19. PubMed ID: 34294164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexually dimorphic skeletal muscle and cardiac dysfunction in a mouse model of limb girdle muscular dystrophy 2i.
    Maricelli JW; Kagel DR; Bishaw YM; Nelson OL; Lin DC; Rodgers BD
    J Appl Physiol (1985); 2017 Nov; 123(5):1126-1138. PubMed ID: 28663375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic disruption of calcineurin improves skeletal muscle pathology and cardiac disease in a mouse model of limb-girdle muscular dystrophy.
    Parsons SA; Millay DP; Sargent MA; Naya FJ; McNally EM; Sweeney HL; Molkentin JD
    J Biol Chem; 2007 Mar; 282(13):10068-10078. PubMed ID: 17289669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.
    Fallon JR; McNally EM
    Matrix Biol; 2018 Aug; 68-69():616-627. PubMed ID: 29481844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice.
    Heydemann A; Ceco E; Lim JE; Hadhazy M; Ryder P; Moran JL; Beier DR; Palmer AA; McNally EM
    J Clin Invest; 2009 Dec; 119(12):3703-12. PubMed ID: 19884661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47.
    Heier CR; McCormack NM; Tully CB; Novak JS; Newell-Stamper BL; Russell AJ; Fiorillo AA
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):940-954. PubMed ID: 36628607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of genetic background on the dystrophic phenotype in mdx mice.
    Coley WD; Bogdanik L; Vila MC; Yu Q; Van Der Meulen JH; Rayavarapu S; Novak JS; Nearing M; Quinn JL; Saunders A; Dolan C; Andrews W; Lammert C; Austin A; Partridge TA; Cox GA; Lutz C; Nagaraju K
    Hum Mol Genet; 2016 Jan; 25(1):130-45. PubMed ID: 26566673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: targeting the renin-angiotensin system.
    Sabharwal R; Chapleau MW
    Exp Physiol; 2014 Apr; 99(4):627-31. PubMed ID: 24334334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between heart and skeletal muscle disease in heart failure: the 2011 George E. Brown Memorial Lecture.
    McNally EM; Goldstein JA
    Circ Res; 2012 Mar; 110(5):749-54. PubMed ID: 22383709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outside in: The matrix as a modifier of muscular dystrophy.
    Quattrocelli M; Spencer MJ; McNally EM
    Biochim Biophys Acta Mol Cell Res; 2017 Mar; 1864(3):572-579. PubMed ID: 28011285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal, cardiac, and respiratory muscle function and histopathology in the P448Lneo- mouse model of FKRP-deficient muscular dystrophy.
    Yu Q; Morales M; Li N; Fritz AG; Ruobing R; Blaeser A; Francois E; Lu QL; Nagaraju K; Spurney CF
    Skelet Muscle; 2018 Apr; 8(1):13. PubMed ID: 29625576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased polyamines as protective disease modifiers in congenital muscular dystrophy.
    Kemaladewi DU; Benjamin JS; Hyatt E; Ivakine EA; Cohn RD
    Hum Mol Genet; 2018 Jun; 27(11):1905-1912. PubMed ID: 29566247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Glycolylneuraminic acid deficiency worsens cardiac and skeletal muscle pathophysiology in α-sarcoglycan-deficient mice.
    Martin PT; Camboni M; Xu R; Golden B; Chandrasekharan K; Wang CM; Varki A; Janssen PM
    Glycobiology; 2013 Jul; 23(7):833-43. PubMed ID: 23514716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
    Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
    EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.